HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
39.2 USD
-0.82 (-2.05%)
39.25 USD
+0.05 (+0.13%)
We assign a fundamental rating of 5 out of 10 to HIMS. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.99%, HIMS belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
With an excellent Return On Equity value of 23.03%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.84%, HIMS is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 6.05%, HIMS belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 63.37% of the companies in the same industry.
HIMS has a Gross Margin of 75.01%. This is amongst the best in the industry. HIMS outperforms 90.10% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.55 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a better Altman-Z score (4.55) than 82.18% of its industry peers.
HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
HIMS has a Debt to FCF ratio of 8.13. This is comparable to the rest of the industry: HIMS outperforms 53.47% of its industry peers.
HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of HIMS (1.67) is worse than 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.55 |
ROIC/WACC0.67
WACC8.78%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 76.24% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS's Quick ratio of 1.64 is fine compared to the rest of the industry. HIMS outperforms 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
The Revenue is expected to grow by 21.08% on average over the next years. This is a very strong growth
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIMS is valuated quite expensively with a Price/Earnings ratio of 72.59.
HIMS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (26.46), we can say HIMS is valued expensively.
With a Price/Forward Earnings ratio of 59.46, HIMS can be considered very expensive at the moment.
HIMS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.10. HIMS is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.59 | ||
| Fwd PE | 59.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 60.40% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.69 | ||
| EV/EBITDA | 51.53 |
4.3 Compensation for Growth
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 16.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.2
EPS Next 2Y10.49%
EPS Next 3Y16.08%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
39.2
-0.82 (-2.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.84%
Ins Owners5.88%
Ins Owner Change-1.82%
Market Cap8.92B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target47.53 (21.25%)
Short Float %32.97%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-4.55%
PT rev (3m)-7.49%
EPS NQ rev (1m)-32.49%
EPS NQ rev (3m)-66.29%
EPS NY rev (1m)-18.96%
EPS NY rev (3m)-18.37%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.59 | ||
| Fwd PE | 59.46 | ||
| P/S | 4.04 | ||
| P/FCF | 74.69 | ||
| P/OCF | 27.45 | ||
| P/B | 15.36 | ||
| P/tB | 70.37 | ||
| EV/EBITDA | 51.53 |
EPS(TTM)0.54
EY1.38%
EPS(NY)0.66
Fwd EY1.68%
FCF(TTM)0.52
FCFY1.34%
OCF(TTM)1.43
OCFY3.64%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1.2
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.55 |
F-Score3
WACC8.78%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.13%
EBIT Next 3Y90.71%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to decline by -9.33% in the next year.